{Reference Type}: Journal Article
{Title}: Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators.
{Author}: Burdis N;Kapnadak SG;Bartlett LE;McElvaney O;Milinic T;Wai TH;Lange AV;Reid N;Dunitz JM;Billings JL;Pilewski JM;Saavedra M;Goss CH;Hartzler AL;Ramos KJ;
{Journal}: BMC Pulm Med
{Volume}: 24
{Issue}: 1
{Year}: 2024 Jul 18
{Factor}: 3.32
{DOI}: 10.1186/s12890-024-03163-x
{Abstract}: <B>BACKGROUND: </B>Outcomes for individuals with cystic fibrosis (CF) have improved due to highly effective modulator therapy (HEMT). However, lung transplant (LTx) remains an important treatment for people with advanced lung disease. This study assessed attitudes and knowledge about LTx in the HEMT era.<BR><B>METHODS: </B>All patients from the University of Washington CF clinic were surveyed March 25-May 30, 2020. Questions addressed self-rated LTx preparedness and knowledge, as well as barriers and facilitators to discussing LTx. Demographic and clinical data were extracted from the electronic health record.<BR><B>RESULTS: </B>There were 159/224 (71%) responses. Respondents had a median forced expiratory volume in one second (FEV1) of 70%, and 142 (89%) were on modulatory therapy. One hundred thirteen (71%) respondents felt that it was moderately or very important to be prepared to make decisions about LTx, though only 56 (35%) felt moderately or very prepared. Only 83 (30%) and 47 (52%) participants correctly answered questions about life expectancy and improved quality of life after LTx, respectively. Respondents with Medicaid insurance less frequently answered questions correctly. The most common barriers to discussing LTx were fear of being a burden on loved ones for 58 respondents (36%) and cost of LTx for 46 (29%). Most participants (94%) trusted their CF doctor, and 75% of participants selected trust as a facilitator for LTx discussions.<BR><B>CONCLUSIONS: </B>Many individuals with CF, especially those with lower socioeconomic status, lacked knowledge and did not feel very prepared for decisions about LTx. Earlier education and discussions about LTx represent an area for improvement in CF care.